Novel therapies in the search for a cure for Huntington's disease

Por Beal, M. Flint, Hantraye, Philippe
Publicado em 2001

Leucine-rich repeat kinase 2: A new player with a familiar theme for Parkinson's disease pathogenesis

Por Li, Chenjian, Beal, M. Flint
Publicado em 2005

Neuroprotective strategies involving ROS in Alzheimer’s disease

Por Dumont, Magali, Beal, M. Flint
Publicado em 2010

Hunting-ton for New Proteases: MMPs as the New Target?

Por Johri, Ashu, Beal, M. Flint
Publicado em 2010

Molecular insights into Parkinson's disease

Por Thomas, Bobby, Beal, M. Flint
Publicado em 2011

Antioxidants in Huntington’s disease

Por Johri, Ashu, Beal, M. Flint
Publicado em 2011

Mitochondrial Dysfunction in Neurodegenerative Diseases

Por Johri, Ashu, Beal, M. Flint
Publicado em 2012

Mitochondrial Therapies for Parkinson’s Disease

Por Thomas, Bobby, Beal, M. Flint
Publicado no Mov Disord (2010)

Neuroprotectiom in CNS diseases /

Por Bär, P.R., Beal, M. Flint
Publicado em 1997

Mitochondrial approaches for neuroprotection

Por Chaturvedi, Rajnish K., Beal, M. Flint
Publicado em 2008

Creatine and Its Potential Therapeutic Value for Targeting Cellular Energy Impairment in Neurodegenerative Diseases

Por Adhihetty, Peter J., Beal, M. Flint
Publicado em 2008

Amyloid beta, mitochondrial dysfunction and synaptic damage: implications for cognitive decline in aging and Alzheimer’s disease

Por Reddy, P. Hemachandra, Beal, M. Flint
Publicado em 2008

Coenzyme Q10 effects in neurodegenerative disease

Por Spindler, Meredith, Beal, M Flint, Henchcliffe, Claire
Publicado em 2009

Autophagy in Neurodegenerative disorders: Pathogenic Roles and Therapeutic Implications

Por Banerjee, Rebecca, Beal, M. Flint, Thomas, Bobby
Publicado em 2010

Mitochondria and Antioxidant Targeted Therapeutic Strategies for Alzheimer's Disease

Por Dumont, Magali, Lin, Michael T., Beal, M. Flint
Publicado em 2010

PGC-1α, Mitochondrial Dysfunction and Huntington’s Disease

Por Johri, Ashu, Chandra, Abhishek, Beal, M. Flint
Publicado em 2013

Prospects for Neuroprotective Therapies in Prodromal Huntington's disease

Por Chandra, Abhishek, Johri, Ashu, Beal, M. Flint
Publicado no Mov Disord (2014)

Alzheimer's brains harbor somatic mtDNA control-region mutations that suppress mitochondrial transcription and replication

Por Coskun, Pinar E., Beal, M. Flint, Wallace, Douglas C.
Publicado em 2004

Mutant Superoxide Dismutase 1 Forms Aggregates in the Brain Mitochondrial Matrix of Amyotrophic Lateral Sclerosis Mice

Por Vijayvergiya, Chetan, Beal, M. Flint, Buck, Jochen, Manfredi, Giovanni
Publicado no J Neurosci (2005)

Mitochondrial dysfunction in the limelight of Parkinson's disease pathogenesis

Por Banerjee, Rebecca, Starkov, Anatoly A., Beal, M. Flint, Thomas, Bobby
Publicado em 2008